Validation and Mechanism Studies of Novel Therapeutic Compounds Modulating Angiogenesis
Discovering novel compounds that stimulate or abrogate angiogenesis can lead to development of new therapeutic agents that may effectively treat diseases with pathological angiogenesis. The zebrafish model allows for a whole-organism approach to drug discovery. Advantages over other animal models in...
Main Author: | Tat, Jennifer |
---|---|
Other Authors: | Wen, Xiao-Yan |
Language: | en_ca |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/1807/35693 |
Similar Items
-
Validation and Mechanism Studies of Novel Therapeutic Compounds Modulating Angiogenesis
by: Tat, Jennifer
Published: (2013) -
Systematic pharmacological screens uncover novel pathways involved in cerebral cavernous malformations
by: Cécile Otten, et al.
Published: (2018-10-01) -
Inhibition of Suicidal Erythrocyte Death by Indirubin-3’-Monoxime
by: Chunqiu Liu, et al.
Published: (2018-02-01) -
Indirubin-3'-monoxime rescues spatial memory deficits and attenuates β-amyloid-associated neuropathology in a mouse model of Alzheimer's disease
by: Yun Ding, et al.
Published: (2010-08-01) -
Indirubin inhibits cell proliferation, migration, invasion and angiogenesis in tumor-derived endothelial cells
by: Li Z, et al.
Published: (2018-05-01)